Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.32)
# 2,584
Out of 5,114 analysts
334
Total ratings
40.26%
Success rate
-0.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $55.86 | +43.22% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $67.35 | +11.36% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $79.57 | -18.31% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $11.29 | +24.00% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $7.88 | +1,169.04% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $31.84 | +41.33% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $21.92 | +242.15% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $25.51 | +17.60% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $17.82 | +146.91% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $21.04 | -52.47% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $33.33 | -70.00% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.23 | +225.03% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $11.27 | +1,009.14% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $18.60 | -19.35% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.22 | +309.84% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $7.19 | -30.46% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.00 | +25.00% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $10.35 | +44.93% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.55 | +118.98% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.34 | +28.21% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.22 | +454.02% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.79 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.76 | +297.73% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $4.27 | -29.74% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.90 | +122.22% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.51 | +496.03% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.11 | +193.54% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $1.17 | +5,916,738,097.42% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.32 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $55.86
Upside: +43.22%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $67.35
Upside: +11.36%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $79.57
Upside: -18.31%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $11.29
Upside: +24.00%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $7.88
Upside: +1,169.04%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $31.84
Upside: +41.33%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $21.92
Upside: +242.15%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $25.51
Upside: +17.60%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $17.82
Upside: +146.91%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $21.04
Upside: -52.47%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $33.33
Upside: -70.00%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $9.23
Upside: +225.03%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $11.27
Upside: +1,009.14%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $18.60
Upside: -19.35%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $7.19
Upside: -30.46%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.00
Upside: +25.00%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $10.35
Upside: +44.93%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.55
Upside: +118.98%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.34
Upside: +28.21%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.22
Upside: +454.02%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.79
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.76
Upside: +297.73%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $4.27
Upside: -29.74%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.90
Upside: +122.22%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.51
Upside: +496.03%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.11
Upside: +193.54%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $1.17
Upside: +5,916,738,097.42%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $7.32
Upside: -